Feasibility and short-term outcome of adjuvant FOLFOX after resection of colorectal liver metastases

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 20, Issue 3, 2013, Pages 307-312

  Sakamoto, Yasuo ^a,b   Beppu, Toru ^a,b   Miyamoto, Yuji ^a   Okabe, Hirohisa ^a   Ida, Satoshi ^a   Imai, Katsunori ^a   Chikamoto, Akira ^a   Watanabe, Masayuki ^a   Takamori, Hiroshi ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adjuvant chemotherapy; Colorectal liver metastases; Disease free survival; Hepatic resection; Overall survival

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ABDOMINAL ABSCESS; ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; COLORECTAL LIVER METASTASIS; CONTINUOUS INFUSION; DIARRHEA; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG DOSE REDUCTION; FATIGUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERBILIRUBINEMIA; LIVER RESECTION; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; POSTOPERATIVE CARE; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE; UNIVERSITY HOSPITAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84879686749     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-012-0523-9     Document Type: Article

References (22)

1. Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ. 1993;306(6880):752-5.
2. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22(1):23-30. doi: 10.1200/JCO.2004.09.046.
3. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350(23):2335-42. doi: 10.1056/NEJMoa032691.
4. Saltz LB, Clarke S, Diaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(12):2013-9. doi: 10.1200/JCO.2007.14. 9930.
5. Bokemeyer C, Bondarenko I, Makhson A, Hartmann JT, Aparicio J, de Braud F, et al. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(5):663-71. doi: 10.1200/JCO.2008.20.8397.
6. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309-18; discussion 18-21.
7. Curley SA. Outcomes after surgical treatment of colorectal cancer liver metastases. Semin Oncol. 2005;32(6 Suppl 9):S109-11. doi: 10.1053/j.seminoncol. 2005.06.011.
8. Kokudo N, Imamura H, Sugawara Y, Sakamoto Y, Yamamoto J, Seki M, et al. Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg. 2004;11(2):84-91. doi: 10.1007/s00534-002-0754-2.
9. Belli G, D'Agostino A, Ciciliano F, Fantini C, Russolillo N, Belli A. Liver resection for hepatic metastases: 15 years of experience. J Hepatobiliary Pancreat Surg. 2002;9(5):607-13. doi: 10.1007/s005340200082.
10. Kuebler JP, Wieand HS, O'Connell MJ, Smith RE, Colangelo LH, Yothers G, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(16):2198-204. doi: 10.1200/JCO.2006.08.2974.
11. Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(6):872-7. doi: 10.1200/JCO.2008.19.5362.
12. Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(19):3109-16. doi: 10.1200/JCO.2008.20. 6771.
13. Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(31):4976-82. doi: 10.1200/JCO.2006.06.8353.
14. Mitry E, Fields AL, Bleiberg H, Labianca R, Portier G, Tu D, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(30):4906-11. doi: 10.1200/JCO.2008.17.3781.
15. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371(9617):1007-16. doi: 10.1016/S0140-6736(08)60455-9.
16. Beppu T, Hayashi N, Masuda T, Komori H, Horino K, Hayashi H, et al. FOLFOX enables high resectability and excellent prognosis for initially unresectable colorectal liver metastases. Anticancer Res. 2010;30(3):1015-20.
17. Komori H, Beppu T, Baba Y, Horino K, Imsung C, Masuda T, et al. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients. Int J Clin Oncol Jpn Soc Clin Oncol. 2010;15(3):263-70. doi: 10.1007/s10147-010-0046-9.
18. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(13):2065-72. doi: 10.1200/JCO.2005.05.3074.
19. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P, et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg. 2008;247(1):118-24. doi: 10.1097/SLA.0b013e31815774de.
20. Beppu T, Sakamoto Y, Hasegawa K, Honda G, Tanaka K, Kotera Y, et al. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci. 2012;19(1):72-84. doi: 10.1007/s00534-011-0460-z.
21. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343-51. doi: 10.1056/NEJMoa032709.
22. Kanemitsu Y, Kato T, Shimizu Y, Inaba Y, Shimada Y, Nakamura K, et al. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603. Jpn J Clin Oncol. 2009;39(6):406-9. doi: 10.1093/jjco/hyp035.